Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Michelle Doo"'
Autor:
Yanci Zhang, Zhiwei Zeng, Maryam S. Mirian, Kevin Yen, Kye Won Park, Michelle Doo, Jun Ji, Zhiqi Shen, Martin J. McKeown
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-17 (2024)
Abstract This study introduces PDMotion, a mobile application comprising 11 digital tests, including those adapted from the MDS-Unified Parkinson's Disease Rating Scale (MDS-UPDRS) Part III and novel assessments, for remote Parkinson's Disease (PD) m
Externí odkaz:
https://doaj.org/article/d27caaf37af24aad84f0e5c777fc060e
Autor:
McKeown, Emad Arasteh, Maryam S. Mirian, Wyatt D. Verchere, Pratibha Surathi, Devavrat Nene, Sepideh Allahdadian, Michelle Doo, Kye Won Park, Somdattaa Ray, Martin J.
Publikováno v:
Journal of Personalized Medicine; Volume 13; Issue 2; Pages: 265
The primary treatment for Parkinson’s disease (PD) is supplementation of levodopa (L-dopa). With disease progression, people may experience motor and non-motor fluctuations, whereby the PD symptoms return before the next dose of medication. Paradox
Autor:
Emad Arasteh, Maryam S. Mirian, Wyatt D. Verchere, Pratibha Surathi, Devavrat Nene, Sepideh Allahdadian, Michelle Doo, Kye Won Park, Somdattaa Ray, Martin J. McKeown
Publikováno v:
Journal of Personalized Medicine. 13:265
The primary treatment for Parkinson’s disease (PD) is supplementation of levodopa (L-dopa). With disease progression, people may experience motor and non-motor fluctuations, whereby the PD symptoms return before the next dose of medication. Paradox
Autor:
Michelle Doose, M. Constanza Camargo, Ligia Artiles, Jarrett A. Johnson, Rina Das, Simrann K. Sidhu, Carolina Solís-Sanabria, Eliseo J. Pérez-Stable, M. Larissa Avilés-Santa
Publikováno v:
The Lancet Regional Health. Americas, Vol 20, Iss , Pp 100479- (2023)
Externí odkaz:
https://doaj.org/article/a42fa881c4664a69aa63ac3a798de529
Autor:
William M. Parkinson, Michelle Dookwah, Mary Lynn Dear, Cheryl L. Gatto, Kazuhiro Aoki, Michael Tiemeyer, Kendal Broadie
Publikováno v:
Disease Models & Mechanisms, Vol 9, Iss 5, Pp 513-527 (2016)
Congenital disorders of glycosylation (CDGs) constitute a rapidly growing family of human diseases resulting from heritable mutations in genes driving the production and modification of glycoproteins. The resulting symptomatic hypoglycosylation cause
Externí odkaz:
https://doaj.org/article/98b6a7d8a49343b58de1cfca70d9ee51